Evidence map›Paper›PMID 18456873›Full record

ArticleThe Journal of pharmacology and experimental therapeutics2008

Reversal of oxidative stress-induced anxiety by inhibition of phosphodiesterase-2 in mice.

Anbrin Masood, Ahmed Nadeem, S Jamal Mustafa, James M O'Donnell

Open access · greenAbstract read
In one paragraph

Article in The Journal of pharmacology and experimental therapeutics, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 91 papers.

0numbers the graph read from it
0cells of the map it votes in
91citing papers in PubMed
4.7field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

91 citing papers in PubMed, 220 citations in OpenAlex.

  1. Activation of TLR4 promotes oxidative inflammation via NADPH oxidase signaling in platelets of subjects with autism spectrum disorder.Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society · 2026
    Article
  2. Article
  3. Article
  4. IRF8 deficiency causes anxiety-like behavior in a sex-dependent manner.bioRxiv : the preprint server for biology · 2025
    Article
  5. Longevity, enhanced memory, and altered density of dendritic spines in hippocampal CA3 and dentate gyrus after hemizygous deletion of Pde2a in mice.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2025
    Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Review
  11. Review
  12. Article
  13. Review
  14. Review
  15. Melatonin as a Potential Approach to Anxiety Treatment.International journal of molecular sciences · 2022
    Review
  16. Alcohol Withdrawal and the Associated Mood Disorders-A Review.International journal of molecular sciences · 2022
    Review
  17. Article
  18. Broccoli Sprouts Promote Sex-Dependent Cardiometabolic Health and Longevity in Long-Evans Rats.International journal of environmental research and public health · 2022
    Article
  19. Article
  20. Article

31 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Anbrin MasoodDepartment of Behavioral Medicine and Psychiatry and Neurobiology and Anatomy, West Virginia University Health Sciences Center, P.O. Box 9128, Morgantown, WV 26506, USA. amasood@hsc.wvu.edu
Ahmed Nadeem
S Jamal Mustafa
James M O'Donnell
West Virginia University · US

Funding

MECHANISMS OF CORONARY FLOW REGULATION BY ADENOSINER01HL027339 · NHLBI · WEST VIRGINIA UNIVERSITY · PI MUSTAFA, S. JAMAL · 1986 to 2015
$5.0M
NEUROPSYCHOPHARMACOLOGY OF CYCLIC AMP PDE INHIBITORSR01MH051175 · NIMH · WEST VIRGINIA UNIVERSITY · PI O'DONNELL, JAMES M · 1995 to 2007
$2.3M
REINFORCEMENT CONTINGENCY AND RESPONSE DIFFERENTIAIONR03MH040964 · NIMH · MCMASTER UNIVERSITY · PI GALBICKA, GREGORY · 1985 to 1985
–
NHLBI NIH HHS HL027339NHLBI NIH HHS R01 HL027339NIMH NIH HHS MH040964NIMH NIH HHS MH051175NIMH NIH HHS R01 MH051175
6 · The paper itself

Abstract

The pathogenesis of several neuropsychiatric disorders, including anxiety and depression, has been linked to oxidative stress, in part via alterations in cyclic nucleotide signaling. Phosphodiesterase-2 (PDE2), which regulates cGMP and cAMP signaling, may affect anxiety-related behavior through reduction of oxidative stress. The present study evaluated the effects of oxidative stress on behavior and assessed the anxiolytic effects of the PDE2 inhibitor Bay 60-7550 [(2-(3,4-dimethoxybenzyl)-7-{(1R)-1-[(1R)-1-hydroxyethyl]-4-phenylbutyl}-5-methyl imidazo-[5,1-f][1,2,4]triazin-4(3H)-one)]. Treatment of mice with L-buthionine-(S,R)-sulfoximine (300 mg/kg), an inducer of oxidative stress, caused anxiety-like behavioral effects in elevated plusmaze, open-field, and hole-board tests through the NADPH oxidase pathway; these effects were antagonized by Bay 60-7550 (3 mg/kg) and apocynin (3 mg/kg), an inhibitor of NADPH oxidase. The Bay 60-7550-mediated decrease in oxidative stress (i.e., superoxide anion and reactive oxygen species generation in cultured neurons and total antioxidant capacity and lipid peroxides in amygdala and hypothalamus) and expression of NADPH oxidase subunits (i.e., p47 phox and gp91 phox expression in amygdala, hypothalamus, and cultured neurons) was associated with increased cGMP and phosphorylation of vasodilator-stimulated phosphoprotein at Ser239, suggesting an important role of cGMP-protein kinase G signaling in reduction of anxiety. Overall, the present results indicate that oxidative stress induces anxiety-like behavior in mice and that PDE2 inhibition reverses it through an increase in cGMP signaling. Thus, PDE2 may be a novel pharmacological target for treatment of anxiety in neuropsychiatric and neurodegenerative disorders that involve oxidative stress.

Indexed as

AnimalsAntioxidantsAnxietyBehavior, AnimalButhionine SulfoximineCells, CulturedCerebral CortexCyclic GMPCyclic Nucleotide Phosphodiesterases, Type 2Disease Models, AnimalLipid PeroxidesMaleMaze LearningMiceMice, Inbred ICRNADPH OxidasesAntioxidantsButhionine SulfoximineCyclic GMPCyclic Nucleotide Phosphodiesterases, Type 2Lipid PeroxidesNADPH OxidasesPhosphodiesterase InhibitorsReactive Oxygen Species

Identifiers

PMID18456873
PMCPMC2913601
OpenAlexW2162572715

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.